Spinal and bulbar muscular atrophy
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
11
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy
12
Clinical Characteristics and Genotype Phenotype Correlation of Korean Patients with Spinal and Bulbar Muscular Atrophy
5
Insulinlike Growth Factor (IGF)-1 Administration Ameliorates Disease Manifestations in a Mouse Model of Spinal and Bulbar Muscular Atrophy
8
Schiffer, Niclas Wilhelm (2008): Investigation of the mechanism of toxicity in newly established models of polyglutamine diseases. Dissertation, LMU München: Fakultät für Chemie und Pharmazie
163
Correlation of clinical and molecular features in spinal bulbar muscular atrophy
9
Pearls & Oy-sters: HyperCKemia with limb-girdle weaknessThink beyond myopathies
5
Special Considerations in the Respiratory Management of Spinal Muscular Atrophy
8
Survival of Patients With Spinal Muscular Atrophy Type 1
8
Polyarticular Arthritis and Spinal Muscular Atrophy in Acid Ceramidase Deficiency
6
Spinal Muscular Atrophy: Survival Pattern and Functional Status
8
Impaired kidney structure and function in spinal muscular atrophy
12
Nusinersen for Type 1 Spinal Muscular Atrophy: A Father’s Perspective
5
A Case Study on Ayurvedic Management of Spinal Muscular Atrophy (SMA)
6
Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
7
Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
10
Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy
17
A qualitative study of perceptions of meaningful change in spinal muscular atrophy
9
Aberrant microRNA Expression in Spinal Muscular Atrophy Motor Neurons
188
A continuous repetitive task to detect fatigability in spinal muscular atrophy
7